AFP and hepatocellular carcinoma: In a nutshell, simvastatin showed ameliorative influences on HCC in regard to tumor mass, serum AFP, liver function tests, hepatitis, fibrosis, dimensioned apoptosis, and unrestrained cancer cell proliferation.